Skip to main content

Mid Year Update

Since we are not quite at the midpoint of 2020, let’s take the opportunity to refocus on a few of YMC’s latest whitepapers and app notes.

YMC for Biologics — Published with the help of Chemical & Engineering News, this whitepaper focuses on the analysis and purification of Biologics. 

Hybrid Silica Advantages — This whitepaper appeared in LCGC Magazine. In it, we explore how hybrid silica can help to make HPLC method development a little easier.

CBD and Melatonin Analysis & CBD Purification — CBD continues to be of high interest to many of our customers for its potential uses and benefits. YMC can help at any scale, from method development through industrial scale production.

Those who are interested in learning more can contact us directly at info@ymcamerica.com. We’re also accepting orders for all HPLC and UHPLC columns, including Triart C-18, Triart Bio C4, and more. Don’t hesitate to contact us today with any questions. 

Posted on June 2, 2020.

Related Posts

Spektra podcast

August 16, 2024

Pasteur-Laria Podcast On YMC Capabilities

Our YMC America employees in Brazil were interviewed on our analytical and process scale systems as well as our HPLC columns with a focus on RP-C18. Check out this great podcast! (It is in Portuguese. Set the captions to your

June 1, 2024

Continuous Chromatography Workshop Set for June 11-13

Gain invaluable insights with both theory and hands-on experience! Dive deeper into the latest advanced purification techniques and optimization strategies that are crucial for next generation rapid drug development evolution that is fundamental to the industry. YMC immersive purification workshops
The YMC America booth at PREP 2024

May 30, 2024

A Lot Happening at PREP 2024!

At PREP in Philadephia, PA, YMC announced our new HT Glass Columns, capable of performing efficiently at temperatures up to 70 °C! They are compatible with all standard separation modes including normal phase, reversed phase, and ion-exchange chromatography. Our crew

Designed and developed by